Cystic Fibrosis

Pediatr Rev. 2021 Feb;42(2):55-67. doi: 10.1542/pir.2019-0212.

Abstract

Cystic fibrosis (CF) is one of the most commonly diagnosed genetic disorders. Clinical characteristics include progressive obstructive lung disease, sinusitis, exocrine pancreatic insufficiency leading to malabsorption and malnutrition, liver and pancreatic dysfunction, and male infertility. Although CF is a life-shortening disease, survival has continued to improve to a median age of 46.2 years due to earlier diagnosis through routine newborn screening, promulgation of evidence-based guidelines to optimize nutritional and pulmonary health, and the development of CF-specific interdisciplinary care centers. Future improvements in health and quality of life for individuals with CF are likely with the recent development of mutation-specific modulator therapies. In this review, we will cover the current understanding of the disease manifestations, diagnosis, and management as well as common complications seen in individuals with CF.

Publication types

  • Review

MeSH terms

  • Bone Density
  • Child
  • Cystic Fibrosis Transmembrane Conductance Regulator / genetics
  • Cystic Fibrosis* / complications
  • Cystic Fibrosis* / diagnosis
  • Cystic Fibrosis* / genetics
  • Cystic Fibrosis* / therapy
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Liver Diseases / etiology
  • Lung / diagnostic imaging
  • Lung Transplantation
  • Male
  • Respiratory Tract Infections / etiology
  • Trypsinogen / blood
  • Vitamins / therapeutic use

Substances

  • CFTR protein, human
  • Vitamins
  • Cystic Fibrosis Transmembrane Conductance Regulator
  • Trypsinogen